Seeing Is Believing
RLAY is currently covered by 11 analysts with an average price target of $17.8. This is a potential upside of $13.6 (323.81%) from yesterday's end of day stock price of $4.2.
Relay Therapeutics 's activity chart (see below) currently has 36 price targets and 68 ratings on display. The stock rating distribution of RLAY is 91.11% BUY and 8.89% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.64% with an average time for these price targets to be met of 30.7 days.
Highest price target for RLAY is $28, Lowest price target is $16, average price target is $17.8.
Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 12-Dec-2024. First documented stock forecast 10-Aug-2020.
Currently out of the existing stock ratings of RLAY, 41 are a BUY (91.11%), 4 are a HOLD (8.89%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$21
$16.29 (345.86%)
$21
6 days ago
(12-Dec-2024)
0/11 (0%)
$16.04 (323.39%)
Buy
$16
$11.29 (239.70%)
$20
14 days ago
(04-Dec-2024)
2/19 (10.53%)
$11.58 (261.99%)
29
Buy
$28
$23.29 (494.48%)
$30
3 months 2 days ago
(16-Sep-2024)
0/6 (0%)
$19.89 (245.25%)
Buy
$21
$16.29 (345.86%)
$23
3 months 8 days ago
(10-Sep-2024)
1/8 (12.5%)
$12 (133.33%)
4
Hold
$16
$11.29 (239.70%)
$10.6
3 months 8 days ago
(10-Sep-2024)
2/4 (50%)
$7 (77.78%)
172
What is RLAY (Relay Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on RLAY (Relay Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on RLAY (Relay Therapeutics )?
Which analyst is the currently most bullish on RLAY (Relay Therapeutics )?
Which analyst is the currently most reserved on RLAY (Relay Therapeutics )?